• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于放射组学分析的肝细胞癌和肝内胆管癌分类。

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.

机构信息

Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

Department of Hepatobiliary Surgery of Drum Tower Clinical Medical College, Nanjing Medical University, Nanjing, China.

出版信息

Comput Math Methods Med. 2022 Feb 21;2022:5334095. doi: 10.1155/2022/5334095. eCollection 2022.

DOI:10.1155/2022/5334095
PMID:35237341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8885247/
Abstract

INTRODUCTION

Considering the narrow window of surgery, early diagnosis of liver cancer is still a fundamental issue to explore. Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICCA) are considered as two different types of liver cancer because of their distinct pathogenesis, pathological features, prognosis, and responses to adjuvant therapies. Qualitative analysis of image is not enough to make a discrimination of liver cancer, especially early-stage HCC or ICCA.

METHODS

This retrospective study developed a radiomic-based model in a training cohort of 122 patients. Radiomic features were extracted from computed tomography (CT) scans. Feature selection was operated with the least absolute shrinkage and operator (LASSO) logistic method. The support vector machine (SVM) was selected to build a model. An internal validation was conducted in 89 patients.

RESULTS

In the training set, the AUC of the evaluation of the radiomics was 0.855 higher than for radiologists at 0.689. In the valuation cohorts, the AUC of the evaluation was 0.847 and the validation was 0.659, which indicated that the established model has a significantly better performance in distinguishing the HCC from ICCA.

CONCLUSION

We developed a radiomic diagnosis model based on CT image that can quickly distinguish HCC from ICCA, which may facilitate the differential diagnosis of HCC and ICCA in the future.

摘要

介绍

考虑到手术的时间窗口很窄,早期诊断肝癌仍然是一个需要探索的基本问题。肝细胞癌(HCC)和肝内胆管细胞癌(ICCA)被认为是两种不同类型的肝癌,因为它们具有不同的发病机制、病理特征、预后和对辅助治疗的反应。图像的定性分析不足以对肝癌进行区分,尤其是早期 HCC 或 ICCA。

方法

本回顾性研究在 122 例患者的训练队列中建立了一个基于放射组学的模型。从计算机断层扫描(CT)扫描中提取放射组学特征。采用最小绝对值收缩和选择算子(LASSO)逻辑方法进行特征选择。选择支持向量机(SVM)来构建模型。在 89 例患者中进行了内部验证。

结果

在训练集中,放射组学评估的 AUC 为 0.855,高于放射科医生的 0.689。在评估队列中,AUC 为 0.847,验证为 0.659,这表明所建立的模型在区分 HCC 和 ICCA 方面具有显著更好的性能。

结论

我们开发了一种基于 CT 图像的放射组学诊断模型,能够快速区分 HCC 和 ICCA,这可能有助于未来 HCC 和 ICCA 的鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/e376c7f7039f/CMMM2022-5334095.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/c0d0e4c79b03/CMMM2022-5334095.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/81b4ac86b7b8/CMMM2022-5334095.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/bb6fef61f645/CMMM2022-5334095.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/e376c7f7039f/CMMM2022-5334095.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/c0d0e4c79b03/CMMM2022-5334095.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/81b4ac86b7b8/CMMM2022-5334095.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/bb6fef61f645/CMMM2022-5334095.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35cc/8885247/e376c7f7039f/CMMM2022-5334095.004.jpg

相似文献

1
Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.基于放射组学分析的肝细胞癌和肝内胆管癌分类。
Comput Math Methods Med. 2022 Feb 21;2022:5334095. doi: 10.1155/2022/5334095. eCollection 2022.
2
Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.计算机断层扫描影像组学用于鉴别肝内胆管癌和肝细胞癌
Clin Oncol (R Coll Radiol). 2023 May;35(5):e312-e318. doi: 10.1016/j.clon.2023.01.018. Epub 2023 Feb 1.
3
Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.基于空间和通道注意力机制的肝细胞癌与肝内胆管癌的鉴别诊断
J Cancer Res Clin Oncol. 2023 Sep;149(12):10161-10168. doi: 10.1007/s00432-023-04935-4. Epub 2023 Jun 2.
4
Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.基于双能量CT的物质分解技术鉴别肝内胆管癌与肝细胞癌
Eur J Radiol. 2022 Nov;156:110556. doi: 10.1016/j.ejrad.2022.110556. Epub 2022 Oct 13.
5
LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.肝脏影像报告和数据系统-超声造影 - 关于高危人群肝细胞癌诊断的超声造影算法提案
Ultraschall Med. 2016 Dec;37(6):627-634. doi: 10.1055/s-0042-112221. Epub 2016 Aug 3.
6
Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.应用贝叶斯方法通过 CT 和 MRI 鉴别肝内肿块型胆管细胞癌和肝细胞癌:一项双中心研究。
Eur Radiol. 2020 Nov;30(11):5992-6002. doi: 10.1007/s00330-020-06972-w. Epub 2020 Jun 4.
7
Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?机器学习放射组学能否提供术前鉴别肝细胞癌合并胆管细胞癌与胆管细胞癌,为最佳治疗方案提供信息?
Eur Radiol. 2021 Jan;31(1):244-255. doi: 10.1007/s00330-020-07119-7. Epub 2020 Aug 4.
8
A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasis.基于不同增强 CT 相位的放射组学模型,用于鉴别肝内胆管细胞癌与伴有肝胆管结石的炎性肿块。
Abdom Radiol (NY). 2021 Aug;46(8):3835-3844. doi: 10.1007/s00261-021-03027-6. Epub 2021 Mar 17.
9
Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.混合型肝细胞癌-胆管细胞癌:2019 年世界卫生组织组织学分类系统的变化及其对基于影像的诊断的潜在影响。
Korean J Radiol. 2020 Oct;21(10):1115-1125. doi: 10.3348/kjr.2020.0091. Epub 2020 Jul 27.
10
Classification of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on multi-phase CT scans.基于多期 CT 扫描的肝细胞癌和肝内胆管细胞癌分类。
Med Biol Eng Comput. 2020 Oct;58(10):2497-2515. doi: 10.1007/s11517-020-02229-2. Epub 2020 Aug 13.

引用本文的文献

1
Application of artificial intelligence in the diagnosis of hepatocellular carcinoma.人工智能在肝细胞癌诊断中的应用。
eGastroenterology. 2023 Nov 30;1(2):e100002. doi: 10.1136/egastro-2023-100002. eCollection 2023 Sep.
2
Artificial Intelligence and Radiomics in Cholangiocarcinoma: A Comprehensive Review.胆管癌中的人工智能与影像组学:综述
Diagnostics (Basel). 2025 Jan 10;15(2):148. doi: 10.3390/diagnostics15020148.
3
Systematic review and meta-analysis on the classification metrics of machine learning algorithm based radiomics in hepatocellular carcinoma diagnosis.

本文引用的文献

1
Predicting cancer outcomes with radiomics and artificial intelligence in radiology.利用放射组学和人工智能技术预测癌症预后。
Nat Rev Clin Oncol. 2022 Feb;19(2):132-146. doi: 10.1038/s41571-021-00560-7. Epub 2021 Oct 18.
2
Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.机器学习方法在周围神经鞘瘤和神经纤维瘤鉴别诊断中的应用:一项多中心研究。
Neuro Oncol. 2022 Apr 1;24(4):601-609. doi: 10.1093/neuonc/noab211.
3
Systematic review: radiomics for the diagnosis and prognosis of hepatocellular carcinoma.
基于机器学习算法的放射组学在肝细胞癌诊断中分类指标的系统评价与荟萃分析
Heliyon. 2024 Aug 14;10(16):e36313. doi: 10.1016/j.heliyon.2024.e36313. eCollection 2024 Aug 30.
4
Fusion of shallow and deep features from F-FDG PET/CT for predicting EGFR-sensitizing mutations in non-small cell lung cancer.融合F-FDG PET/CT的浅层和深层特征以预测非小细胞肺癌中的EGFR敏感突变。
Quant Imaging Med Surg. 2024 Aug 1;14(8):5460-5472. doi: 10.21037/qims-23-1028. Epub 2024 Jan 19.
5
Applications of artificial intelligence in biliary tract cancers.人工智能在胆道癌中的应用。
Indian J Gastroenterol. 2024 Aug;43(4):717-728. doi: 10.1007/s12664-024-01518-0. Epub 2024 Mar 1.
6
Application of AI on cholangiocarcinoma.人工智能在胆管癌中的应用。
Front Oncol. 2024 Jan 29;14:1324222. doi: 10.3389/fonc.2024.1324222. eCollection 2024.
7
Artificial Intelligence in Liver Diseases: Recent Advances.人工智能在肝脏疾病中的应用:最新进展。
Adv Ther. 2024 Mar;41(3):967-990. doi: 10.1007/s12325-024-02781-5. Epub 2024 Jan 29.
8
Differentiation of Hepatocellular Carcinoma from Intrahepatic Cholangiocarcinoma through MRI Radiomics.通过MRI影像组学鉴别肝细胞癌与肝内胆管癌
Cancers (Basel). 2023 Nov 11;15(22):5373. doi: 10.3390/cancers15225373.
9
Lightweight neural network for smart diagnosis of cholangiocarcinoma using histopathological images.基于组织病理学图像的胆管癌智能诊断轻量化神经网络
Sci Rep. 2023 Nov 1;13(1):18854. doi: 10.1038/s41598-023-46152-6.
10
Update on the Applications of Radiomics in Diagnosis, Staging, and Recurrence of Intrahepatic Cholangiocarcinoma.肝脏内胆管癌的影像组学在诊断、分期及复发中的应用进展
Diagnostics (Basel). 2023 Apr 20;13(8):1488. doi: 10.3390/diagnostics13081488.
系统评价:放射组学在肝细胞癌诊断和预后中的应用。
Aliment Pharmacol Ther. 2021 Oct;54(7):890-901. doi: 10.1111/apt.16563. Epub 2021 Aug 12.
4
Development and Validation of a Radiomics Model for Differentiating Bone Islands and Osteoblastic Bone Metastases at Abdominal CT.基于腹部 CT 影像的骨岛与成骨性骨转移瘤的影像组学模型的建立与验证
Radiology. 2021 Jun;299(3):626-632. doi: 10.1148/radiol.2021203783. Epub 2021 Mar 30.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma.抗 CD147 嵌合抗原受体靶向治疗肝细胞癌的疗效。
Nat Commun. 2020 Sep 23;11(1):4810. doi: 10.1038/s41467-020-18444-2.
7
A radiomics-based model on non-contrast CT for predicting cirrhosis: make the most of image data.基于影像组学的非增强CT预测肝硬化模型:充分利用图像数据。
Biomark Res. 2020 Sep 17;8:47. doi: 10.1186/s40364-020-00219-y. eCollection 2020.
8
Consensus recommendations of three-dimensional visualization for diagnosis and management of liver diseases.肝脏疾病诊断和管理的三维可视化共识建议。
Hepatol Int. 2020 Jul;14(4):437-453. doi: 10.1007/s12072-020-10052-y. Epub 2020 Jul 7.
9
Regional Chemotherapy for Biliary Tract Tumors and Hepatocellular Carcinoma.胆管肿瘤和肝细胞癌的区域化疗
Surg Oncol Clin N Am. 2019 Oct;28(4):717-729. doi: 10.1016/j.soc.2019.06.008. Epub 2019 Aug 7.
10
Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.多中心研究表明,基于磁共振灌注成像的放射组学特征可识别胶质母细胞瘤的假性进展。
Nat Commun. 2019 Jul 18;10(1):3170. doi: 10.1038/s41467-019-11007-0.